l-carnitine tmao koeth 2013 nature medicine γ–Butyrobetaine is a pro-atherogenic intermediate in gut microbial metabolism of to L-Carnitine intake and high trimethylamine

L Carnitine intake and high trimethylamine N oxide plasma levels correlate with low aortic lesions in ApoE transgenic mice expressing CETP ScienceDirect Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L Carnitine to TMAO: Cell Metabolism Gut Metabolite Trimethylamine N Oxide in Atherosclerosis: From Mechanism to Therapy Frontiers Meat metabolizing bacteria in atherosclerosis Nature Medicine Innovative carnitine fed rats model reveals resveratrol butyrate Ester's multimechanistic role in reducing TMAO and cardiovascular risk ScienceDirect

SKU: 91883648592 · From mlbdaktechniek.nl